Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020.
Oluwafemi BalogunAshley BrownKristina M AngeloNatasha S HochbergElizabeth D BarnettLaura Ambra NicoliniHilmir AsgeirssonMartin P GrobuschKarin LederFernando SalvadorLin ChenSilvia OdoliniMarta Diaz MenéndezFederico GobbiBradley A ConnorMichael D LibmanDavidson H HamerPublished in: Journal of travel medicine (2022)
Despite availability of highly effective vaccines, travellers still acquire hepatitis A, even when traveling to low-endemicity destinations. Providing pre-departure hepatitis A vaccine to susceptible travellers is crucial to reducing travel-associated hepatitis A and should be offered to all travellers as part of the pre-travel consultation, regardless of destination.